ATE314086T1 - Arginin deiminase aus mycoplasma arthirtidis und sie enthaltende polymerkonjugate - Google Patents

Arginin deiminase aus mycoplasma arthirtidis und sie enthaltende polymerkonjugate

Info

Publication number
ATE314086T1
ATE314086T1 AT98903799T AT98903799T ATE314086T1 AT E314086 T1 ATE314086 T1 AT E314086T1 AT 98903799 T AT98903799 T AT 98903799T AT 98903799 T AT98903799 T AT 98903799T AT E314086 T1 ATE314086 T1 AT E314086T1
Authority
AT
Austria
Prior art keywords
arginine deiminase
adi
polymer conjugates
mycoplasma
arthirtidis
Prior art date
Application number
AT98903799T
Other languages
English (en)
Inventor
David Ray Filpula
Maoliang Wang
Original Assignee
Enzon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzon Inc filed Critical Enzon Inc
Application granted granted Critical
Publication of ATE314086T1 publication Critical patent/ATE314086T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT98903799T 1997-01-31 1998-01-27 Arginin deiminase aus mycoplasma arthirtidis und sie enthaltende polymerkonjugate ATE314086T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/792,283 US5804183A (en) 1997-01-31 1997-01-31 Arginine deminase derived from mycoplasma arthritidis and polymer conjugates containing the same
PCT/US1998/001635 WO1998033519A1 (en) 1997-01-31 1998-01-27 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same

Publications (1)

Publication Number Publication Date
ATE314086T1 true ATE314086T1 (de) 2006-01-15

Family

ID=25156365

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98903799T ATE314086T1 (de) 1997-01-31 1998-01-27 Arginin deiminase aus mycoplasma arthirtidis und sie enthaltende polymerkonjugate

Country Status (9)

Country Link
US (3) US5804183A (de)
EP (1) EP1011717B1 (de)
JP (1) JP4126097B2 (de)
AT (1) ATE314086T1 (de)
AU (1) AU6047598A (de)
DE (1) DE69832993T2 (de)
DK (1) DK1011717T3 (de)
ES (1) ES2255147T3 (de)
WO (1) WO1998033519A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183738B1 (en) * 1997-05-12 2001-02-06 Phoenix Pharamacologics, Inc. Modified arginine deiminase
US6635462B1 (en) * 1997-05-12 2003-10-21 Phoenix Pharmacologies, Inc. Mutated form of arginine deiminase
EP1337630A2 (de) * 2000-11-28 2003-08-27 Phoenix Pharmacologics, Inc. Modifizierte arginin-deiminase
US6645739B2 (en) * 2001-07-26 2003-11-11 Phoenix Pharmacologies, Inc. Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same
US8129330B2 (en) 2002-09-30 2012-03-06 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
US20040062748A1 (en) * 2002-09-30 2004-04-01 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
CA2506244C (en) * 2002-11-18 2012-10-30 Phoenix Pharmacologics, Inc. Methods for inhibiting viral replication in vivo
FR2884717B1 (fr) * 2005-04-25 2009-07-03 Erytech Pharma Soc Par Actions Erythrocytes renfermant de l'arginine deiminase
WO2007130453A2 (en) 2006-05-02 2007-11-15 Allozyne, Inc. Non-natural amino acid substituted polypeptides
US20080096819A1 (en) * 2006-05-02 2008-04-24 Allozyne, Inc. Amino acid substituted molecules
FR2919804B1 (fr) 2007-08-08 2010-08-27 Erytech Pharma Composition et vaccin therapeutique anti-tumoral
CA2707840A1 (en) * 2007-08-20 2009-02-26 Allozyne, Inc. Amino acid substituted molecules
JP2009044997A (ja) * 2007-08-20 2009-03-05 Sony Corp ビリルビンオキシダーゼ（ｂｏｄ）の被覆方法
EP2295560A1 (de) 2009-09-14 2011-03-16 RWTH Aachen University Zielgerichtete Evolution von Arginindeiminase zur erhöhten Aktivität im physiologischen pH
USRE48805E1 (en) 2013-03-06 2021-11-02 Vision Global Holdings Ltd. Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion protein
US9255262B2 (en) * 2013-03-06 2016-02-09 Vision Global Holdings Ltd. Albumin-binding arginine deminase and the use thereof
EP3744341A1 (de) 2013-03-15 2020-12-02 TDW Group Arginin-deiminase mit verminderter kreuzreaktivität gegenüber adi-peg-20-antikörpern zur krebsbehandlung
KR102523031B1 (ko) * 2014-03-18 2023-04-19 티디더블유 그룹 조작된 키메라성 페길화된 adi 및 사용 방법
AU2015317848B2 (en) 2014-09-16 2021-04-22 Polaris Group Arginine deiminase with reduced cross-reactivity toward ADI - PEG 20 antibodies for cancer treatment
US11613759B2 (en) 2015-09-04 2023-03-28 Sqz Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall
JP7602702B2 (ja) 2016-05-03 2024-12-19 ステムセル テクノロジーズ カナダ インコーポレーテッド 寛容性を誘導するための生体分子の細胞内送達
TWI847958B (zh) 2016-07-05 2024-07-11 英屬開曼群島商北極星藥業集團股份有限公司 用精胺酸耗盡劑進行之組合癌症免疫療法
EP3534963B1 (de) 2016-11-02 2024-04-17 Polaris Group Formulierungen von pegylierter arginin-deiminase
CN116143678A (zh) 2016-11-14 2023-05-23 杭州多禧生物科技有限公司 偶联连接体，含有此连接体的细胞结合分子-药物偶联物及其制备和应用
US12344645B2 (en) 2017-03-29 2025-07-01 Polaris Group Protein conjugates
WO2019042628A1 (en) 2017-08-31 2019-03-07 Erytech Pharma ARGININE DEIMINASE ENCAPSULATED WITHIN ERYTHROCYTES AND THEIR USE IN THE TREATMENT OF CANCER AND ARGINASE-1 DEFICIENCY
EP3449935A1 (de) 2017-08-31 2019-03-06 Erytech Pharma In erythrozyten eingekapselte arginin-deiminase und deren verwendung zur behandlung von krebs und arginase-1-mangel
EP4007768A4 (de) * 2019-08-01 2023-11-15 The University of North Carolina at Chapel Hill Zusammensetzungen und verfahren zum binden von antikörpern und zur hemmung von neutralisierenden antikörpern
CA3128035A1 (en) 2020-08-13 2022-02-13 Bioasis Technologies, Inc. Combination therapies for delivery across the blood brain barrier
US20240309055A1 (en) * 2021-02-03 2024-09-19 The University Of North Carolina At Chapel Hill Protein m analogs and fusion proteins and their use for inhibiting antibody function
WO2022078524A2 (en) 2021-11-03 2022-04-21 Hangzhou Dac Biotech Co., Ltd. Specific conjugation of an antibody

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPH0253490A (ja) * 1988-08-16 1990-02-22 Agency Of Ind Science & Technol アルギニン・デイミナーゼ遺伝子
US5122614A (en) * 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
JP2900279B2 (ja) * 1989-08-02 1999-06-02 株式会社ジャパンエナジー 新規なアルギニンデイミナーゼ、その製造法及び該酵素を有効成分とする制癌剤
JP3209338B2 (ja) * 1990-09-10 2001-09-17 株式会社ジャパンエナジー ポリエチレングリコール修飾アルギニンデイミナーゼおよびその製造法
US5372942A (en) * 1992-02-10 1994-12-13 Coriell Institute For Medical Research Protease K resistant arginine deiminase, its method of preparation and its use as an anti-neoplastic agent
US5349001A (en) * 1993-01-19 1994-09-20 Enzon, Inc. Cyclic imide thione activated polyalkylene oxides
US5359030A (en) * 1993-05-10 1994-10-25 Protein Delivery, Inc. Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same

Also Published As

Publication number Publication date
WO1998033519A1 (en) 1998-08-06
US5804183A (en) 1998-09-08
DE69832993T2 (de) 2006-09-07
EP1011717A1 (de) 2000-06-28
JP4126097B2 (ja) 2008-07-30
AU6047598A (en) 1998-08-25
EP1011717A4 (de) 2003-02-19
US6132713A (en) 2000-10-17
DK1011717T3 (da) 2006-05-15
JP2001512965A (ja) 2001-08-28
US5916793A (en) 1999-06-29
DE69832993D1 (de) 2006-02-02
ES2255147T3 (es) 2006-06-16
EP1011717B1 (de) 2005-12-28

Similar Documents

Publication Publication Date Title
ATE314086T1 (de) Arginin deiminase aus mycoplasma arthirtidis und sie enthaltende polymerkonjugate
ATE284954T1 (de) Hyaluronan synthase gen und seine verwendung
BR9913360B1 (pt) proteÍna de uricase recombinante quimÉrica, molÉcula de Ácido nuclÉico isolada e purificada, vetor e cÉlula hospedeira transformada.
KR960031608A (ko) 바실러스-유래 트랜스글루타미나제
DE69131580D1 (de) GDF-1 und UOG1 Proteine
ZA967173B (en) Purified coprinus laccases and nucleic acids and encoding same
AP1678A (en) Novel modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems.
BR9804896A (pt) Dna isolado e purificado, célula hospedeira, vetor, polinucleotídeo quimérico, plasmídeo e processo para aumentar a transcrição de um gene de interesse em uma célula hospedeira
ATE358724T1 (de) Expression regulierende sequenzen vom schimmelpilz chrysosporium
BR0010114A (pt) Vetor biologicamente funcional, molécula de dna, molécula de dna codificada para ribozima, método de clonagem de uma transferase g1cnac-a-1.3-fucosil, método de preparação de células hospedeiras recombinantes, células de plantas recombinantes, insetos ou células de insetos recombinantes, molécula de ácido nucléico de peptìdeo (pna), método de produção de plantas ou insetos ou células, método de produção de glicoproteìnas recombinantes, método de produção de glicoproteìnas humanas, recombinantes, método de produção de gligoproteìnas humanas, recombinantes para uso médico, método de seleção de moléculas de dna codificada para uma transferase g1cnac-a-1,-3-fucosil em uma amostra
WO1998021343B1 (en) Genes encoding telomerase proteins
BR9909346A (pt) Segmento de ácido nucleico, vetor recombinante, célula hospedeira, composição, processos para detectar uma espécie de dna, uma célula bacteriana e infecção, para produzir ácido hialurÈnico e para criar uma vacina, sequência de ácido nucleico e de cdna, vacina e teste diagnóstico
CA2252493A1 (en) .beta.-galactoside - .alpha. 2,6-sialyltransferase gene
TR200700067T2 (tr) Corynebacterium glutamicum gen kodlayıcı fosfoenol piruvat : şeker fosfotransferaz sistem proteini
KR970001542A (ko) 엔도글리코세라미데이즈 유전자
CA2384122A1 (en) Cyclic depsipeptide synthetase and gene thereof, and mass production system for cyclic depsipeptide
FI953688A0 (fi) Kasvinsuojeluominaisuudet omaava proteiini
WO2002010384A1 (en) Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin
WO2002057412A3 (en) Plant promoters, and methods of use
Iwamoto et al. Subunit structures of three human myeloperoxidases
WO2002010383A1 (en) Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin
EP0924295A3 (de) DNS kodierend für Neospora Dihydrofolatreductase-Thymidylate Synthase
WO2003050302A3 (en) Tgnp activity or expression as marker for apoptosis
WO2003048361A3 (en) P55pik
WO2002061039A3 (en) Thuja plicata dirigent protein promotors

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1011717

Country of ref document: EP

REN Ceased due to non-payment of the annual fee